This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hirotani, T. Articles by Yamano, M. Search for Related Content PubMed PubMed Citation Articles by Hirotani, T. Articles by Yamano, M.

Effects of coronary artery bypass grafting using internal mammary arteries for diabetic patients

^a Department of Cardiovascular Surgery, Tokyo Saiseikai Central Hospital, Tokyo, Japan

View larger version (24K): [in a new window]   Figure 1 Overall survival curves, cardiac death–free curves and cardiac event–free curves were compared by using the Kaplan–Meier method between nondiabetic and diabetic patients. DM = diabetes mellitus.

View larger version (22K): [in a new window]   Figure 2 Overall survival curves, cardiac death–free curves and cardiac event–free curves in nondiabetic patients were compared according to conduits used for coronary revascularization. Internal mammary artery (IMA) grafts conferred no long-term benefit to nondiabetic patients.

View larger version (22K): [in a new window]   Figure 3 Overall survival curves, cardiac death–free curves and cardiac event–free curves in diabetic patients were compared according to conduits used for coronary revascularization. In each of these curves, it was demonstrated that diabetic patients who underwent coronary artery bypass grafting with at least one internal mammary artery (IMA) graft received significantly more benefit than those with saphenous veins alone (p < 0.01).